These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23113231)

  • 1. Overview of blood transfusion system of iran: 2002-2011.
    Cheraghali A
    Iran J Public Health; 2012; 41(8):89-93. PubMed ID: 23113231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience.
    Cheraghali AM; Abolghasemi H
    Haemophilia; 2009 Mar; 15(2):487-93. PubMed ID: 19347989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four decades of National Blood Service in Iran: outreach, prospect and challenges.
    Pourfathollah AA; Hosseini Divkolaye NS; Seighali F
    Transfus Med; 2015 Jun; 25(3):138-43. PubMed ID: 26040645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety.
    Omidkhoda A; Razi B; Arabkhazaeli A; Amini Kafi-Abad S
    BMC Infect Dis; 2020 Oct; 20(1):736. PubMed ID: 33028232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A successful experience of the Iranian blood transfusion organization in improving accessibility and affordability of plasma derived medicine.
    Chegini A; Torab SA; Pourfatollah AA
    Transfus Apher Sci; 2017 Feb; 56(1):12-16. PubMed ID: 28214180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study.
    Farshadpour F; Taherkhani R; Tajbakhsh S; Gholizadeh Tangestani M; Hajiani G; Sharifi N; Taherkhani S; Nejadbolkheyr A
    PLoS One; 2016; 11(6):e0157615. PubMed ID: 27309959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence and trends in transfusion transmissible infections among voluntary non-remunerated blood donors at the Malawi Blood Transfusion Service-a time trend study.
    M'baya B; Jumbe V; Samuel V; M'bwana R; Mangani C
    Malawi Med J; 2019 Jun; 31(2):118-125. PubMed ID: 31452844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability of blood components and plasma derived medicines in Iran.
    Cheraghali AM
    Transfus Apher Sci; 2007 Aug; 37(1):3-7. PubMed ID: 17707696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013.
    Keshvari M; Sharafi H; Alavian SM; Mehrabadi H; Zolfaghari S
    Transfus Apher Sci; 2015 Aug; 53(1):38-47. PubMed ID: 25892591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review of Transfusion-Transmissible Infections Among Blood Donors and Associated Safety Challenges in Pakistan.
    Ehsan H; Wahab A; Shafqat MA; Sana MK; Khalid F; Abdullah SM; Jaan A; Sheikh MM; Muneeb A; Ehsan S; Khan AY; Iftikhar R; Anwer F
    J Blood Med; 2020; 11():405-420. PubMed ID: 33173367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economical impact of plasma fractionation project in Iran on affordability of plasma-derived medicines.
    Cheraghali AM; Aboofazeli R
    Transfus Med; 2009 Dec; 19(6):363-8. PubMed ID: 19778319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Source Plasma Donation: The Experience of the Iranian Blood Transfusion Organization.
    Mohammadi S; Aghabozorg F; Balagholi S; Ferdowsi S; Sharifi S; Eshghi P
    Int J Hematol Oncol Stem Cell Res; 2022 Jul; 16(3):151-156. PubMed ID: 36694705
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of repeated blood donations on the iron status of Iranian blood donors attending the Iranian blood transfusion organization.
    Djalali M; Neyestani TR; Bateni J; Siassi F
    Int J Vitam Nutr Res; 2006 May; 76(3):132-7. PubMed ID: 17048192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of transfusion-transmissible infection in blood donors in Thammasat University Hospital between 2007-2012.
    Chiamchanya N
    J Med Assoc Thai; 2014 Oct; 97(10):1055-63. PubMed ID: 25632622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H
    Transfus Med; 2009 Aug; 19(4):189-94. PubMed ID: 19708860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique.
    Stokx J; Gillet P; De Weggheleire A; Casas EC; Maendaenda R; Beulane AJ; Jani IV; Kidane S; Mosse CD; Jacobs J; Bottieau E
    BMC Infect Dis; 2011 May; 11():141. PubMed ID: 21605363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability, safety and quality of blood for transfusion in the Americas.
    Cruz JR; Pérez-Rosales MD
    World Hosp Health Serv; 2005; 41(1):25, 27-31. PubMed ID: 15881823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Availability, safety, and quality of blood for transfusion in the Americas.
    Cruz JR; Pérez-Rosales MD
    Rev Panam Salud Publica; 2003; 13(2-3):103-10. PubMed ID: 12744785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of transfusion transmitted infection among blood donors at Jijiga blood bank, Eastern Ethiopia: retrospective 4 years study.
    Mohammed Y; Bekele A
    BMC Res Notes; 2016 Feb; 9():129. PubMed ID: 26922241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.